Ayr Wellness Signs Definitive Agreement To Acquire Owner Of Levia Cannabis Infused Seltzers

By Louise Sommerfeld On Sep 7, 2021

Ayr Wellness Inc. (CNSX: AYR.A, OTCMKTS: AYRWF), a leading vertically integrated cannabis multi-state operator (“MSO”), has announced that it has moved to a definitive agreement for its previously announced plan to acquire Cultivauna, LLC, the owner of Levia branded cannabis infused seltzers and water-soluble tinctures.

Since we first announced our intention to acquire Levia a few weeks ago, we have been thrilled with the feedback we’ve received from customers, friends, investors and industry colleagues about how much they’ve enjoyed the cannabis experience Levia brings. It is a truly unique product that we believe will be game changing to the mainstreaming of cannabis in the U.S. With a formula that provides consistently great flavor and zero calories in an infused beverage experience, we believe Levia has enormous potential as an alcohol alternative. As we finalize our updated national brand portfolio to address all segments and form factors, Levia will, following closing, play a marquee role in each market where we operate, joining our other national brands, Kynd premium flower and Origyn extracts.
Jonathan Sandelman, CEO of Ayr Wellness

Ayr intends to purchase 100% of the equity interests of Cultivauna, LLC. The terms of the transaction include $20 million in upfront consideration, made up of up to $10 million in cash with the remainder in stock. An earn-out payment of up to an additional $40 million will be paid in shares based on the achievement of revenue targets in 2022 and 2023.

Levia Cannabis Infused Seltzer is currently available in Massachusetts in three experiences and flavors:

“Achieve” Raspberry Lime (Sativa)
“Celebrate” Lemon Lime (Hybrid)
“Dream” Jam Berry (Indica)

Levia Cannabis Infused Seltzer Beverages Lineup

Each flavor is available in 12-ounce slim cans and contains 5 mgs of THC. Levia is also available in water soluble tinctures in the same formulations.

Levia uses a proprietary technology which provides for rapid onset of the effects of THC, typically 15-20 minutes and the effects last up to 3 hours, allowing for a more consistent consumption experience than many edible products.

The acquisition is subject to customary closing conditions and regulatory approvals. The acquisition is expected to close by the end of 2021.

To view the original press release in its entirety click here